FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for quetiapine fumarate from Hikma Pharmaceuticals USA, indicating approval of changes to the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine fumarate (Quetiapine fumarate)

Snippet

SUPPL AP for QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)